• Carfilzomib (PR-171): Proteasome Inhibition in Oncology Work

  2026-05-29

  Carfilzomib (PR-171) stands out for its robust, irreversible proteasome inhibition, enabling multi-modal apoptosis induction in cancer research. This article details experimental protocols, troubleshooting insights, and cross-study innovations to help researchers optimize their use of Carfilzomib in translational oncology.

• RBMS1 Loss Enhances PD-L1 Blockade Response in TNBC

  2026-05-29

  This study uncovers RBMS1 as a key regulator of PD-L1 stability in triple-negative breast cancer (TNBC), demonstrating that RBMS1 loss sensitizes tumors to immune checkpoint therapies by promoting PD-L1 degradation. The findings highlight a novel mechanistic axis and offer new avenues for improving immunotherapy response in immune-cold TNBC.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): T

  2026-05-28

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) facilitate efficient capture, purification, and isolation of biotinylated molecules from complex samples, reducing background binding in workflows such as immunoprecipitation and protein interaction studies. This product should be reserved for applications that leverage the biotin-streptavidin interaction on hydrophobic bead surfaces, and is not suitable for workflows outside affinity capture or where hydrophobicity may interfere with results.

• IGF2BP3 Depletion Triggers Ferroptosis in Glioma via GPX4 Mo

  2026-05-28

  This study reveals that the m6A reader protein IGF2BP3 directly regulates GPX4 expression in glioma, and its depletion induces ferroptosis by destabilizing GPX4 mRNA at a specific m6A site. These findings clarify a novel post-transcriptional mechanism controlling ferroptosis and underscore the therapeutic potential of targeting IGF2BP3–GPX4 interactions in glioma.

• In Vitro Efficacy of Temafloxacin Versus Quinolones Against

  2026-05-27

  This literature review examines the in vitro potency of temafloxacin, a fluoroquinolone, against a spectrum of gram-negative bacteria, benchmarking its minimal inhibitory concentrations (MICs) versus established quinolone antibiotics such as cinoxacin. The findings clarify temafloxacin’s comparative advantages and inform experimental antibiotic selection in urinary tract and antibiotic resistance research.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Me

  2026-05-27

  Xiao et al. (2024) uncover a lysosomal 25-hydroxycholesterol (25HC)–AMPK–STAT6 axis that metabolically reprograms tumor-associated macrophages (TAMs) toward an immunosuppressive state. The study identifies CH25H as an immunometabolic checkpoint, suggesting new targets for modulating the tumor microenvironment and enhancing immunotherapy efficacy.

• TiO2-Nanoparticle Sonodynamic Therapy Induces Ferroptosis to

  2026-05-26

  The referenced study demonstrates that titanium dioxide nanoparticle-enhanced sonodynamic therapy (SDT) can effectively prevent posterior capsule opacification after cataract surgery by inducing ferroptosis in human lens epithelial cells. This mechanism, characterized by ROS accumulation and GPX4 downregulation, offers a targeted, biosafe approach that addresses a persistent complication in ophthalmology.

• Targeting SNORA38B Modulates NSCLC Tumorigenesis and Immunit

  2026-05-26

  This study reveals that SNORA38B, a small nucleolar RNA, promotes tumor growth and immune evasion in non-small cell lung cancer (NSCLC) by regulating the GAB2/AKT/mTOR pathway. Targeting SNORA38B not only reduces tumorigenic potential but also sensitizes tumors to immune checkpoint blockade, highlighting its potential as a therapeutic target.

• Phenothiazines Induce ROS and Autophagy to Boost Macrophage

  2026-05-25

  This study demonstrates that phenothiazine compounds, including promethazine hydrochloride, significantly enhance the antibacterial activity of macrophages by inducing reactive oxygen species (ROS) and autophagy. These host-directed effects offer a promising research avenue for circumventing antibiotic resistance and improving outcomes against intracellular infections.

• Firefly Luciferase mRNA: Applied 5-moUTP Reporter Workflows

  2026-05-25

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) delivers robust, immune-evasive bioluminescence for gene regulation and mRNA delivery studies. This guide translates recent microfluidic mixing advances and optimized protocols into actionable workflows and troubleshooting strategies for bench and translational research.

• Applied Workflows for Y-27632: ROCK Inhibitor in Cancer Biol

  2026-05-24

  Y-27632 stands out as a selective ROCK inhibitor enabling precise cytoskeletal modulation and reproducible stress fiber disruption in advanced cell biology and cancer research. This guide delivers actionable workflows, real-world troubleshooting, and evidence-based insights for maximizing experimental success with APExBIO’s benchmark Y-27632.

• Benzyl-activated Streptavidin Magnetic Beads in Advanced Pur

  2026-05-23

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) set a new standard for rapid, high-specificity capture of biotinylated molecules, minimizing background and enabling reproducible results across immunoprecipitation and protein interaction studies. Their unique surface chemistry and optimized protocols empower researchers to streamline complex workflows while maintaining assay fidelity.

• Improving Assay Reliability with EZ Cap™ Firefly Luciferase

  2026-05-22

  This article explores how EZ Cap™ Firefly Luciferase mRNA (SKU R1018) addresses reproducibility and sensitivity challenges in cell-based assays. Scenario-driven Q&A blocks provide data-backed insights into protocol optimization, product selection, and workflow compatibility for biomedical researchers. The practical guidance is grounded in scientific evidence and real laboratory needs.

• Nitrocefin: Chromogenic Cephalosporin Substrate in β-Lactama

  2026-05-22

  Nitrocefin from APExBIO enables rapid, sensitive detection of β-lactamase activity, accelerating resistance profiling and inhibitor screening. Its robust colorimetric shift, proven in both clinical and bench workflows, makes it a gold-standard substrate for β-lactam antibiotic resistance research and advanced enzymatic assays.

• Hepatic Cellular Interactions of PEGylated Iron Oxide Nanopa

  2026-05-21

  This study systematically deciphers how iron oxide nanoparticle size and PEGylation dictate their uptake by distinct liver cell populations. The findings challenge longstanding models of hepatic clearance, revealing new design principles for nanomedicine targeting and safety.

16695 records 1/1113 page Next 12345 下5页 Last page